Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Virus-like particle-based vaccine against coxsackievirus A6 protects mice against lethal infections

22 Jun 2016

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Disease Management and Epidemiology
Share to Viral gastroenteritis research and epidemiology
Share to Viral Infections and Immunology Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 27340093
DOI: 10.1016/j.vaccine.2016.06.028

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Virus-like particle-based vaccine against coxsackievirus A6 protects mice against lethal infectionsPMID 27340093Read ↗

Virus-like particle-based vaccines for animal viral infectionsSemantic proximity Read ↗

Virus like particle-based vaccines against emerging infectious disease virusesSemantic proximity Read ↗

Virus-like particles: The new frontier of vaccines for animal viral infectionsSemantic proximity Read ↗

Developments in virus-like particle-based vaccines for infectious diseases and cancerSemantic proximity Read ↗

The coming of age of virus-like particle vaccinesSemantic proximity Read ↗

Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical developmentSemantic proximity Read ↗

Yeast-produced recombinant virus-like particles of coxsackievirus A6 elicited protective antibodies in miceSemantic proximity Read ↗

Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infectionsSemantic proximity Read ↗

Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancerSemantic proximity Read ↗

Safety and immunogenicity of a virus-like particle Chikungunya virus vaccineSemantic proximity Read ↗

Comparative Efficacy of Mayaro Virus-Like Particle Vaccines Produced in Insect or Mammalian CellsSemantic proximity Read ↗

Virus-like particle-based human vaccines: quality assessment based on structural and functional propertiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.